Cargando…
Metabolic Bone Diseases and New Drug Developments
Metabolic bone diseases are serious health issues worldwide, since several million individuals over the age of 50 are at risk of bone damage and should be worried about their bone health. One in every two women and one in every four men will break a bone during their lifetime due to a metabolic bone...
Autores principales: | Natesan, Vijayakumar, Kim, Sung-Jin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Korean Society of Applied Pharmacology
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9252877/ https://www.ncbi.nlm.nih.gov/pubmed/35342038 http://dx.doi.org/10.4062/biomolther.2022.007 |
Ejemplares similares
-
Lipid Metabolism, Disorders and Therapeutic Drugs – Review
por: Natesan, Vijayakumar, et al.
Publicado: (2021) -
Diabetic Nephropathy – a Review of Risk Factors, Progression, Mechanism, and Dietary Management
por: Natesan, Vijayakumar, et al.
Publicado: (2021) -
The Trend of Organic Based Nanoparticles in the Treatment of Diabetes and Its Perspectives
por: Natesan, Vijayakumar, et al.
Publicado: (2023) -
Antiepileptic drugs and bone metabolism
por: Valsamis, Helen A, et al.
Publicado: (2006) -
p-Coumaric Acid Nanoparticles Ameliorate Diabetic Nephropathy via Regulating mRNA Expression of KIM-1 and GLUT-2 in Streptozotocin-Induced Diabetic Rats
por: Venkatesan, Amalan, et al.
Publicado: (2022)